Graphene and 2D materials for biomedical applications
3 European H2020 organizations list this as part of their work — 2 as their primary capability.
Most active in this area
- BOSTON SCIENTIFIC LIMITED
Global medical device company contributing implant design, biomaterials expertise, and manufacturing scale-up to European biomedical research consortia.
“Participated in GrapheneCore2, GrapheneCore3, and 2D-EPL pilot line — all within the Graphene Flagship, with keywords including biomedical technologies and sensors.”
PrimaryIE13 projects - GUGER TECHNOLOGIES OG
Austrian SME building brain-computer interface systems for clinical neurology, with growing expertise in graphene and advanced materials for biosensors.
“Participated in GrapheneCore1, GrapheneCore2, GrapheneCore3, and the 2D Experimental Pilot Line, contributing to biomedical and sensor workpackages.”
SMEAT9 projects - MEDICA S.P.A.
Italian medical technology company contributing to graphene industrialization and 2D materials pilot line manufacturing within the EU Graphene Flagship.
“Participated in all three Graphene Flagship phases (Core2, Core3, 2D-EPL), with biomedical technologies as a tagged keyword in Core2.”
PrimaryIT3 projects